Compound corresponding to general formula (I), in which R2 represents a hydrogen or fluorine atom or a hydroxyl, C1-6-alkyl or NR8R9 group； n represents an integer equal to 1, 2 or 3 and m represents an integer equal to 1 or 2； A represents a covalent bond or a C1-8-alkylene group； R1 represents a group R5 optionally substituted with one or more groups R6 and/or R7； R5 represents a group chosen from phenyl, pyridinyl, pyridazinyl, pyrimidinyl, pyrazinyl, quinolinyl, isoquinolinyl, phthalazinyl and quinoxalinyl； R6 represents a halogen atom, a nitro group, C1-6-alkyl, C1-6-alkoxy, C1-6-haloalkyl, C1-6-haloalkoxy or -O-(C1-3-alkylene)-O- group； R7 represents phenyl possibly being substituted with one or more groups R6 that may be identical to or different from each other； R3 represents a trifluoromethyl group, a group C1-6-alkyl or a hydrogen atom； R4 represents a group chosen from furanyl, oxazolyl, isoxazolyl, pyrazolyl, oxadiazolyl, thiadiazolyl, imidazolyl and triazolyl； this group being optionally substituted with one or more substituents chosen from a group C1-6-alkyl, CO2R8, CONR8R9, CON(R8)(C1-3-alkylene-NR10R11) and phenyl； wherein phenyl possibly being substituted with one or more substituents chosen from a halogen atom and C1-6-alkoxy； R8, R9, R10 and R11 represent, independently of each other, a hydrogen atom or a group C1-6-alkyl, or form, with the atom(s) that bear(s) them, in the case of NR8R9, a piperazine ring, this ring being optionally substituted with a group C1-6-alkyl； in the form of base or of an acid-addition salt； to the therapeutic use thereof.Изобретение относится к соединению, отвечающему общей формуле (I), в которой R2 означает атом водорода или фтора либо гидроксил, C1-6-алкил или группу NR8R9； n означает целое число, равное 1, 2 или 3, и m означает целое число, равное 1 или 2； А означает ковалентную связь или C1-8-алкиленовую группу； R1 означает группу R5, необязательно замещенную одной или несколькими группами R6 и/или R7； R5 означает г
